POSSIBLE DOPAMINE DERIVATIVES CAPABLE OF CROSSING BLOOD-BRAIN BARRIER IN RELATION TO PARKINSONISM

被引:19
作者
PINDER, RM
机构
关键词
D O I
10.1038/228358a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:358 / &
相关论文
共 16 条
[1]  
BARBEAU A, 1967, REV CAN BIOL EXPTL, V26, P55
[2]  
BROOKS CJW, 1960, ANAL CHEM, V36, P1540
[3]  
CALNE DB, 1969, LANCET, V2, P973
[4]  
CALNE DB, 1969, LANCET, V1, P744
[5]   MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J].
COTZIAS, GC ;
PAPAVASI.PS ;
GELLENE, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) :337-&
[6]   LABILE LIPOPHILIC DERIVATIVES OF NOREPINEPHRINE CAPABLE OF CROSSING BLOOD-BRAIN BARRIER [J].
CREVELING, CR ;
DALY, JW ;
TOKUYAMA, T ;
WITKOP, B .
EXPERIENTIA, 1969, 25 (01) :26-+
[7]  
CURZON G, 1968, INT REV NEUROBIOL, V10, P323
[8]   CHEMORELEASE OF NOREPINEPHRINE FROM MOUSE HEARTS . STRUCTURE-ACTIVITY RELATIONSHIPS .I. SYMPATHOMIMETIC AND RELATED AMINES [J].
DALY, JW ;
CREVELING, CR ;
WITKOP, B .
JOURNAL OF MEDICINAL CHEMISTRY, 1966, 9 (03) :273-+
[9]  
ERNST AM, 1969, ACTA PHYSIOL PHARM N, V15, P141
[10]   PHARMACOLOGICAL ASPECTS OF PARKINSONISM [J].
FRIEDMAN, AH ;
EVERETT, GM .
ADVANCES IN PHARMACOLOGY, 1964, 3 :83-127